SCHEMBL5314935

SCHEMBL5314935

CCCON=C(COc1cc(C(=O)OC)cc(C(F)(F)F)c1)c1cccc(Oc2ccccc2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY1 P47900 1/20 0.40
NOTUM Q6P988 1/20 0.39
NR1H2 P55055 2/20 0.39
NR1H3 Q13133 1/20 0.39
CETP P11597 1/20 0.39
MAPT P10636 4/20 0.38
ALDH1A1 P00352 2/20 0.38
LMNA P02545 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ALOX12 P18054 1/20 0.38
CCR6 P51684 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
FABP1 P07148 1/20 0.38
NPC1 O15118 2/20 0.37
POLB P06746 2/20 0.37
RAB9A P51151 2/20 0.37
CYP2C9 P11712 1/20 0.37
BLM P54132 1/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5314934 1.00 P2RY1 (0.40) P2RY1NOTUMNR1H2NR1H3CETP
SCHEMBL5313658 0.92 KMT2A (0.44) MAPTALDH1A1LMNASMN1; SMN2ALOX12
SCHEMBL5313656 0.92 KMT2A (0.44) MAPTALDH1A1LMNASMN1; SMN2ALOX12
SCHEMBL5313433 0.83 RAB9A (0.47) MAPTALDH1A1LMNASMN1; SMN2FABP1
SCHEMBL5313429 0.83 RAB9A (0.47) MAPTALDH1A1LMNASMN1; SMN2FABP1
SCHEMBL5312906 0.81 KMT2A (0.59) ALDH1A1LMNASMN1; SMN2FABP1NPC1
SCHEMBL5312903 0.81 KMT2A (0.59) ALDH1A1LMNASMN1; SMN2FABP1NPC1
SCHEMBL14530963 0.78 KMT2A (0.47) MAPTALDH1A1LMNASMN1; SMN2FABP1
SCHEMBL5309885 0.76 PLA2G4B (0.50) ALDH1A1LMNASMN1; SMN2FABP1KMT2A
SCHEMBL5309894 0.76 PLA2G4B (0.50) ALDH1A1LMNASMN1; SMN2FABP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007058504-A1 NOVEL COMPOUNDS AS AGONIST FOR PPAR GAMMA AND PPAR ALPHA, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME LG LIFE SCIENCES, LTD. (KR) 2007-05-24 WO disclosed